Jefferies Group LLC Novo Nordisk A S Transaction History

Jefferies Group LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$49.46 - $64.78 $453,993 - $594,615	-9,179 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$49.86 - $58.26 $457,664 - $534,768	9,179 New	9,179 $531,000
Q3 2019 Nov 13, 2019	SELL	$47.54 - $53.43 $4.41 Million - $4.95 Million	-92,685 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$46.79 - $52.47 $1.98 Million - $2.22 Million	42,322 Added 84.03%	92,685 $4.73 Million
Q1 2019 May 15, 2019	BUY	$46.36 - $52.63 $1.86 Million - $2.11 Million	40,184 Added 394.77%	50,363 $2.63 Million
Q4 2018 Feb 14, 2019	SELL	$41.54 - $47.25 $307,977 - $350,311	-7,414 Reduced 42.14%	10,179 $469,000
Q3 2018 Nov 14, 2018	BUY	$46.76 - $51.24 $593,524 - $650,389	12,693 Added 259.04%	17,593 $829,000
Q2 2018 Aug 14, 2018	SELL	$44.29 - $50.42 $738,668 - $840,904	-16,678 Reduced 77.29%	4,900 $226,000
Q1 2018 May 15, 2018	BUY	$48.49 - $58.14 $1.05 Million - $1.25 Million	21,578 New	21,578 $1.06 Million

1,954

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $237B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.